The Effectiveness and Safety of Triple-Antiplatelet Treatment Based on Cilostazol for Patients Receiving Percutaneous Coronary Intervention: A Meta-Analysis-Reference-Cited by-同舟云学术

The Effectiveness and Safety of Triple-Antiplatelet Treatment Based on Cilostazol for Patients Receiving Percutaneous Coronary Intervention: A Meta-Analysis

Published:2012-05-14 Issue:10 Volume:35 Page:598-604
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Wang Ping,Zhou Shijie,Zhou Rui,Liu Gan,Tang Ping,He Jing,Ma Cong,He Yi,Yang Jinliang

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/clc.22001/fullpdf

Reference34 articles.

1. Retrospective comparison of a strategy of primary coronary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction in a community hospital without cardiac surgical backup.;Brush;J Invasive Cardiol.,1996

2. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.;Weaver;JAMA.,1997

3. Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease.;Fischman;N Engl J Med.,1994

4. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials.;Cutlip;J Am Coll Cardiol.,2002

5. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials.;Kastrati;JAMA.,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Randomized Controlled Trial Evaluating Outcome Impact of Cilostazol in Patients with Coronary Artery Disease or at a High Risk of Cardiovascular Disease;Journal of Personalized Medicine;2022-06-06

2. Update on Cilostazol: A Critical Review of Its Antithrombotic and Cardiovascular Actions and Its Clinical Applications;The Journal of Clinical Pharmacology;2021-11-25

3. Increased bleeding events with the addition of apixaban to the dual anti-platelet regimen for the treatment of patients with acute coronary syndrome;Medicine;2021-03-26

4. Comparison of Minimally Invasive Direct Coronary Artery Bypass and Percutaneous Coronary Intervention Using Second-Generation Drug-Eluting Stents for Coronary Artery Disease　― Propensity Score-Matched Analysis ―;Circulation Journal;2019-06-25

5. Effects of Cilostazol-Based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation: An Updated Meta-Analysis of the Randomized Controlled Trials;Clinical Drug Investigation;2018-09-24